RE: Significant Inflection11 Apr 2018 00:03
NW agree with display analysis. The following is from the interim accounts as a principle risk of the directors
" Revenues with the new US partner could become the major part of our revenues which could lead to over-reliance on that partner"
They obviously believe revenues from the nanoparticle business will be significant. The mitigating factor is the growth of revenue from other sources. So it would appear the income will potential outstrip the display income despite the fact that will be significant